Jasper Therapeutics, Inc.
JSPR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$71 | -$64 | -$38 | -$31 |
| Dep. & Amort. | $1 | $1 | $1 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $7 | $5 | $0 | $1 |
| Change in WC | $0 | $5 | -$1 | $2 |
| Other Non-Cash | $1 | $1 | -$9 | -$6 |
| Operating Cash Flow | -$63 | -$52 | -$46 | -$34 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$1 | -$0 | -$1 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$1 | -$0 | -$1 | -$2 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $47 | $101 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | -$1 | $0 | $101 |
| Financing Cash Flow | $48 | $101 | $0 | $101 |
| Forex Effect | $0 | $0 | -$0 | $0 |
| Net Chg. in Cash | -$15 | $49 | -$46 | $65 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $87 | $39 | $85 | $20 |
| End Cash | $72 | $87 | $38 | $85 |
| Free Cash Flow | -$63 | -$52 | -$46 | -$36 |